In vitro results are a promising starting point, but skin is far more complex than a dish, so they don't automatically translate into visible results on your face
Semaglutide has revolutionized medical weight loss, delivering results that were previously only achievable through bariatric surgery
Ciardullo, Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Capacity and Production Issues: Internal Manufacturing Capacity: Novo Nordisk : Began 2023 with one contract manufacturing filling line for Wegovy, added a second in H1 2023, and plans a third by 2024
Our approach is simple: we prioritise food quality, sleep, and movement first, then we supplement with intention to fill the genuine gaps